牛牛AI助手已提取核心信息中国中药控股公布2025年中期业绩,期内营业额约74.6亿元人民币,同比下降11.0%。毛利约36.3亿元人民币,同比下降10.5%;毛利率为48.7%,较去年同期上升0.3个百分点。期内净亏损约1.42亿元人民币,去年同期盈利2.14亿元人民币。业务结构方面,中药配方颗粒业务营收约29.9亿元人民币,同比下降14.1%,占总营业额40.1%;中成药业务营收约23.1亿元...
Source Link牛牛AI助手已提取核心信息中国中药控股公布2025年中期业绩,期内营业额约74.6亿元人民币,同比下降11.0%。毛利约36.3亿元人民币,同比下降10.5%;毛利率为48.7%,较去年同期上升0.3个百分点。期内净亏损约1.42亿元人民币,去年同期盈利2.14亿元人民币。业务结构方面,中药配方颗粒业务营收约29.9亿元人民币,同比下降14.1%,占总营业额40.1%;中成药业务营收约23.1亿元...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.